163 related articles for article (PubMed ID: 9893017)
1. Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours.
Wulbrand U; Wied M; Zöfel P; Göke B; Arnold R; Fehmann H
Eur J Clin Invest; 1998 Dec; 28(12):1038-49. PubMed ID: 9893017
[TBL] [Abstract][Full Text] [Related]
2. mRNA expression patterns of insulin-like growth factor system components in human neuroendocrine tumours.
Wulbrand U; Remmert G; Zöfel P; Wied M; Arnold R; Fehmann HC
Eur J Clin Invest; 2000 Aug; 30(8):729-39. PubMed ID: 10964166
[TBL] [Abstract][Full Text] [Related]
3. Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells.
Wimmel A; Wiedenmann B; Rosewicz S
Gut; 2003 Sep; 52(9):1308-16. PubMed ID: 12912863
[TBL] [Abstract][Full Text] [Related]
4. Growth factor mRNA and protein in preserved human amniotic membrane.
Koizumi NJ; Inatomi TJ; Sotozono CJ; Fullwood NJ; Quantock AJ; Kinoshita S
Curr Eye Res; 2000 Mar; 20(3):173-7. PubMed ID: 10694891
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours.
de Herder WW; Hofland LJ; van der Lely AJ; Lamberts SW
Endocr Relat Cancer; 2003 Dec; 10(4):451-8. PubMed ID: 14713257
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of epidermal growth factor and hepatocyte growth factor receptors in a proportion of gastrinomas correlates with aggressive growth and lower curability.
Peghini PL; Iwamoto M; Raffeld M; Chen YJ; Goebel SU; Serrano J; Jensen RT
Clin Cancer Res; 2002 Jul; 8(7):2273-85. PubMed ID: 12114431
[TBL] [Abstract][Full Text] [Related]
7. Polypeptide growth factors in gastroenteropancreatic neuroendocrine tumours.
Blicharz-Dorniak J; Kos-Kudła B; Kudła M; Foltyn W; Marek B; Siemińska L; Nowak M
Endokrynol Pol; 2007; 58(1):42-9. PubMed ID: 17354204
[TBL] [Abstract][Full Text] [Related]
8. Expression of alternatively spliced growth factor receptor isoforms in the human trabecular meshwork.
Wordinger RJ; Clark AF; Agarwal R; Lambert W; Wilson SE
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):242-7. PubMed ID: 9888450
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours.
Nilsson O; Wängberg B; Kölby L; Schultz GS; Ahlman H
Int J Cancer; 1995 Mar; 60(5):645-51. PubMed ID: 7860139
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of somatostatin receptor-2 positivitiy in gastroenteropancreatic neuroendocrine tumors in reference to known prognostic factors.
Yenıay L; Gürcü B; Ünalp Ö; Yilmaz F; Nart D; Sözbılen M; Çoker A
Turk J Gastroenterol; 2012; 23(6):736-40. PubMed ID: 23794313
[TBL] [Abstract][Full Text] [Related]
11. Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy.
Kaemmerer D; Träger T; Hoffmeister M; Sipos B; Hommann M; Sänger J; Schulz S; Lupp A
Oncotarget; 2015 Sep; 6(29):27566-79. PubMed ID: 26259237
[TBL] [Abstract][Full Text] [Related]
12. PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms.
Briest F; Grabowski P
Theranostics; 2014; 4(4):336-65. PubMed ID: 24578720
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta1, FGF-2, and receptor mRNA expression in suture mesenchyme and dura versus underlying brain in fusing and nonfusing mouse cranial sutures.
Gosain AK; Recinos RF; Agresti M; Khanna AK
Plast Reconstr Surg; 2004 May; 113(6):1675-84. PubMed ID: 15114129
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies.
Lambertini C; Barzaghi-Rinaudo P; D'Amato L; Schulz S; Nuciforo P; Schmid HA
Regul Pept; 2013 Nov; 187():35-41. PubMed ID: 24188818
[TBL] [Abstract][Full Text] [Related]
15. Expression of somatostatin and dopamine 2 receptors in neuroendocrine tumours and the potential role for new biotherapies.
Srirajaskanthan R; Watkins J; Marelli L; Khan K; Caplin ME
Neuroendocrinology; 2009; 89(3):308-14. PubMed ID: 19307732
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas.
Papouchado B; Erickson LA; Rohlinger AL; Hobday TJ; Erlichman C; Ames MM; Lloyd RV
Mod Pathol; 2005 Oct; 18(10):1329-35. PubMed ID: 15920550
[TBL] [Abstract][Full Text] [Related]
17. Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis.
Wang DG; Johnston CF; Buchanan KD
Cancer; 1997 Aug; 80(4):668-75. PubMed ID: 9264349
[TBL] [Abstract][Full Text] [Related]
18. Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours.
Chiti A; Fanti S; Savelli G; Romeo A; Bellanova B; Rodari M; van Graafeiland BJ; Monetti N; Bombardieri E
Eur J Nucl Med; 1998 Oct; 25(10):1396-403. PubMed ID: 9818279
[TBL] [Abstract][Full Text] [Related]
19. The expression of NeuroD and mASH1 in the gastroenteropancreatic neuroendocrine tumors.
Shida T; Furuya M; Kishimoto T; Nikaido T; Tanizawa T; Koda K; Oda K; Takano S; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Nakatani Y; Miyazaki M
Mod Pathol; 2008 Nov; 21(11):1363-70. PubMed ID: 18587321
[TBL] [Abstract][Full Text] [Related]
20. Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.
John M; Meyerhof W; Richter D; Waser B; Schaer JC; Scherübl H; Boese-Landgraf J; Neuhaus P; Ziske C; Mölling K; Riecken EO; Reubi JC; Wiedenmann B
Gut; 1996 Jan; 38(1):33-9. PubMed ID: 8566856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
